EDITORIAL
INTRODUCTION
The innovation of precision medicine holds the potential promise of a scientific, personalised, patient-centred and patient-centric, holistic approach that, for the first time in human history, may provide an individual with the detailed view of their genetic markers and predispositions in the context of their environment and actions. That it may individually lead to a more precise and individual focus for prevention appears to be without doubt. This evolving opportunity enabled by knowledge and technology may see precise personal information and its consequent specific motivation replace a more usual patient-centred diet of information predicated on a cohort risk analysis and spur of threat-borne fear.
Whether or not one has used a telescope, an instinctive understanding of its purpose exists through a common understanding of its design. By viewing a scene through the eyepiece, an image at once appears closer and detail hitherto unseen now appears visible. If the scene is instead viewed through the objective lens of the instrument, an impractically small image is seen in which detail is absent. Indeed, this idea is so familiar that it has become a figure of speech. Perceiving a problem through the wrong end of the telescope is a well-understood metaphor.
With the advent and growth of precision medicine 1 described as "an emerging approach for disease treatment and prevention, which takes into account individual variability in environment, lifestyle and genes for each person", 2 we witness the installation of greater scientific meaning to the hackneyed phrases "holistic" and "patient-centred". The National Institutes of Health Precision Medicine Initiative (NIH PMI) "All of Us" has been funded with USD $215 million and a stated aim of capturing the data from one million participants. 4 Individual biology is predicated upon the statistical risk derived from a cohort and its associations, something that patients often intuitively appreciate and health professionals know well.
To an individual patient or in public health, evidencebased "risk-mongering" may form the basis of today's professional advice and health policy, but have you noticed that it is inevitably accompanied by researchers, health professionals, public health advisers, and politicians bemoaning the guaranteed failure to achieve a preconceived target of individual or public adherence? The circularity of this observation is as worrying as it is obvious-"Evidence-based policy cannot be separated from policy-based evidence" 5 lending itself readily to the development of the distorted societal state of "hypocognition". 5 Moreover, a fundamental disconnect appears between the tellers and the told, with the latter recognising that a statement of calculated statistical risk is not an absolute truth capable of reflecting an accurate personal description of an individual's biology or context. I believe that both patients and the wider public intuitively recognise this, instinctively weighing perceived risk against the stated calculated risk when undertaking health decision.
Human beings execute an unending stream of personal decisions predicated on an instinctive or sometimes more formal evaluation of the risk-benefit ratio. In this personal process, absolute risk as opposed to relative risk appears to be the currency of choice, though the latter inevitably remains the omnipresent marketing megaphone and chief currency of "risk-mongering". The two currencies do not have equivalence. While absolute risk is founded on an informational gold standard, relative risk is in comparison a kind of fiat currency, that is, an intrinsically worthless currency founded upon a perceived marketing value rather than one based on any intrinsic or representative absolute value. Take, for example, the recent changes in public policy around fat and sugar. Butter once demonized is now not so bad in moderation. Sugar is now the new butter.
In the statistical analysis around risk, have we forgotten that patients are human beings cortically hardwired to accept a multitude of risk that permeates every single aspect of their lives and their behaviour on a daily basis? Telling a lie and weighing the odds on being found out, or gambling upon not arriving late, are just trivial examples of a constant living stream of risk-benefit analysis that we all instinctively and routinely undertake. The constellation of well-publicised risks potentially acting on an individual's health span 6 may inform an individual's existence, but it joins a very long queue of risk. After all, human existence is finite and imbued from birth with an absolute risk of 100 per cent in the certainty of mortality. While personal tolerance may vary when an individual weighs a threat to their health-span, human behaviour exemplifies risk and more, it appears extremely well adapted to it. On the other hand, contemporaneous societal mores that appear inclined toward a social construct that is more notably risk averse. 7 Tomasetti and Vogelstein disturbed the guardians of public health with the publication of their illuminating research in Science in January 2015, which quantified the genetic and environmental contribution to a range of common cancers displayed in a telling graphic image of stochastic (replicative) factors versus environmental and inherited factors. 8 
Their abstract states:

These results suggest that only a third of the variation in cancer risk among tissues is attributable to environmental factors or inherited predispositions.
The majority is due to 'bad luck', that is, random mutations arising during DNA replication in normal, noncancerous stem cells. This is important not only for understanding the disease but also for designing strategies to limit the mortality it causes. 8 They further explained:
1. All cancers are caused by a combination of bad luck, the environment and heredity-the model they developed may help quantify how much each factor, respectively, contributes to cancer development. If we are to enhance a patient's insight of his/her healthspan risks, surely the development of a therapeutic relationship that has at its heart a context of intellectual integrity must be used to frame advisory language, which better reflects the limitations that professionals understand and patients intuitively suspect. The necessity of balancing biological inevitability against personal and environmental risk while appreciating an individual's humanity, that is, his/her dynamic and fluid threshold of tolerance to personal risk, may lead to a more persuasive intellectual appeal. Treating people as an end point in a policy-and funding-driven algorithm of clinical "policybased" practice may not. People instinctively perceive from which end of the telescope their health information arises.
Until precision medicine becomes a part of routine medical practice and to some extent supplants the high level of reliance placed on an epidemiological projection of individual risk based on the statistical analysis of a cohort, an entirely natural threshold of individual risk tolerance appears potentially likely to persist as one of several ceilings that can inhibit patient participation both with an individual practitioner and with wider public health messages. Recognition of this limitation may also assist a practitioner toward considering engagement with a model of patient-centric care, which may have the added utility of reducing the burden on a single knowledge authority. Such an approach may help facilitate patient engagement by positioning the patient at the centre of a dialogue with a variety of medical, healthcare, and fitness providers.
Such positioning may be augmented and supported by technology, particularly around the recording, weighing, and encouragement of lifestyle choice and prevention to which this model may appear better suited than, for example, the management of a dreaded disease, which requires a patient-centred approach, where the practitioner occupies out of necessity, a patient-engaged central position at the centre of complex medical information.
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